• Price (EUR)116.14
  • Today's Change-0.82 / -0.70%
  • Shares traded0.00
  • 1 Year change+58.10%
  • Beta--
Data delayed at least 15 minutes, as of Dec 02 2022.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Events & Activity

  • AB3A:STU price moved over +4.29% to 113.76

Key statistics

On Friday, Sarepta Therapeutics Inc (AB3A:STU) closed at 116.14, -2.55% below its 52-week high of 119.18, set on Sep 09, 2022.
52-week range
55.16Jan 24 2022119.18Sep 09 2022
Markit short selling activity
Previous close116.96
Average volume0.00
Shares outstanding87.78m
Free float83.68m
P/E (TTM)--
Market cap11.08bn USD
EPS (TTM)-8.21
Data delayed at least 15 minutes, as of Dec 02 2022.
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.